The UFC career of Alvin Hines is in serious jeopardy. The heavyweight, who lost his Octagon debut at UFC 317 earlier this year, has been suspended for a year after a failed drug test.
Hines, who took a bout with Jhonata Diniz on short notice in June, tested positive for the anabolic steroid Drostanolone, the promotion announced. The test results were released by Combat Sports Anti-Doping (CSAD).
MORE: Dana White still has trust with Conor McGregor to make big fights
A native of Minnesota, Hines was also found to have 3a-Hydroxy-2a-methyl-5a-androstan-17-one and testosterone metabolites, as well as a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen, a hormone and metabolic modulator in his system. The tests were take from samples collected both in-competition and out-of-competition.
In the release, the UFC noted that the cases reflected that Hines consumed the substances that are banned before he was signed to the UFC, but that he also failed to disclose taking them when his onboarding into the UFC Anti-Doping Program was completed just days before his bout.
"Under the UFC ADP, CSAD evaluates each case and can reduce periods of ineligibility based on the athlete’s degree of fault and their level of cooperation," the UFC said in a statement. " While Hines failed to disclose his prior use of these substances during onboarding, the estimated concentrations of these substances in Hines’ samples were reflective that they were near the tail end of excretion and supported his explanation of their use prior to being signed to the UFC and entering the UFC registered testing pool."
The suspension started on July 11, 2025 and runs for one year.
MORE COMBAT SPORTS NEWS:
- PFL sets pair of championship matches for upcoming event
- How to watch UFC in 2026 on Paramount+
- Alexander Volkanovski previews UFC 319 co-main event
- Complete MMA schedule for 2025